Skip to main content
Skip to footer
Home
Triverity
Education
Acute infection & sepsis
Immune Response
Machine Learning
Advocacy
Evidence
Publications
Abstracts
Pipeline
News
News
Press Release
ML Blogs
Podcasts
Media contact
Careers
About
Leadership
Investors
Partner with us
Awards
Certificates
Reach out
Home
Triverity
Education
Acute infection & sepsis
Immune Response
Machine Learning
Advocacy
Evidence
Publications
Abstracts
Pipeline
News
News
Press Release
ML Blogs
Podcasts
Media contact
Careers
About
Leadership
Investors
Partner with us
Awards
Certificates
Reach out
Reach out
Category:
News
Immune cell ‘signatures’ could help guide treatment for critically ill patients
September 30, 2025
TriVerity Test Demonstrates High Accuracy in Differentiating Bacterial Versus Viral Infections
July 24, 2025
FDA clears acute infection and sepsis test
May 6, 2025
Recognizing It Early While Getting It Right: The Value of Novel Sepsis Testing Tools
April 2, 2025
A better, faster sepsis test that can save lives
February 6, 2025
Inflammatix Gets FDA Clearance for 30-Minute Sepsis Test, Preps for US Launch
January 21, 2025
Inflammatix Scores FDA Approval for Precision Infection Test
January 21, 2025
Inflammatix begins trial evaluating mRNA test for patient infection status
November 12, 2024
Inflammatix Adds MedTech Veteran as First General Counsel
October 10, 2024
Inflammatix Raises $57M in Series E Financing
September 12, 2024
←
1
2
3
4
…
8
→
September 30, 2025July 24, 2025
May 6, 2025
April 2, 2025February 6, 2025January 21, 2025January 21, 2025November 12, 2024October 10, 2024September 12, 2024
